118 related articles for article (PubMed ID: 27001432)
1. Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Pyo JS; Sohn JH; Kang G
Hum Pathol; 2016 Jul; 53():91-6. PubMed ID: 27001432
[TBL] [Abstract][Full Text] [Related]
2. Medullary carcinoma of the large intestine: a population based analysis.
Thirunavukarasu P; Sathaiah M; Singla S; Sukumar S; Karunamurthy A; Pragatheeshwar KD; Lee KK; Zeh H; Kane KM; Bartlett DL
Int J Oncol; 2010 Oct; 37(4):901-7. PubMed ID: 20811712
[TBL] [Abstract][Full Text] [Related]
3. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
4. Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases.
Knox RD; Luey N; Sioson L; Kedziora A; Clarkson A; Watson N; Toon CW; Cussigh C; Pincott S; Pillinger S; Salama Y; Evans J; Percy J; Schnitzler M; Engel A; Gill AJ
Ann Surg Oncol; 2015 Sep; 22(9):2988-96. PubMed ID: 25572685
[TBL] [Abstract][Full Text] [Related]
5. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum.
Takahashi S; Kohashi K; Yamamoto H; Hirahashi M; Kumagai R; Takizawa N; Nakamura K; Maehara Y; Tanaka M; Takayanagi R; Oda Y
Hum Pathol; 2015 Sep; 46(9):1257-66. PubMed ID: 26208847
[TBL] [Abstract][Full Text] [Related]
6. Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database.
Jabbal IS; Nagarajan A; Rivera C; Yaghi M; Liang H; Nahleh Z; Bejarano P; Berho M; Wexner S
Surg Oncol; 2022 Dec; 45():101856. PubMed ID: 36446307
[TBL] [Abstract][Full Text] [Related]
7. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
9. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
10. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
[TBL] [Abstract][Full Text] [Related]
11. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
12. [Development of molecular-pathologic entities of colorectal cancer].
Kirchner T; Reu S
Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367
[TBL] [Abstract][Full Text] [Related]
13. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
14. Primary Colonic Medullary Carcinoma With Exclusive Squamous Differentiation.
Chen IY; Findeis-Hosey JJ; Cannon L; Liao X
Anticancer Res; 2021 Jul; 41(7):3567-3572. PubMed ID: 34230152
[TBL] [Abstract][Full Text] [Related]
15. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.
Lee LH; Yantiss RK; Sadot E; Ren B; Calvacanti MS; Hechtman JF; Ivelja S; Huynh B; Xue Y; Shitilbans T; Guend H; Stadler ZK; Weiser MR; Vakiani E; Gönen M; Klimstra DS; Shia J
Hum Pathol; 2017 Apr; 62():74-82. PubMed ID: 28034727
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
Kim JH; Bae JM; Song YS; Cho NY; Lee HS; Kang GH
Oncotarget; 2016 Mar; 7(12):13372-87. PubMed ID: 26528695
[TBL] [Abstract][Full Text] [Related]
18. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
19. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
Lanza G; Gafà R; Matteuzzi M; Santini A
J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
[TBL] [Abstract][Full Text] [Related]
20. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
